In silico analysis of REMBRANDT data set confirmed increased SPT6 expression in malignant gliomas (compared to NB) to be negatively correlated with patients’ survival (Supplementary Fig. 7e–f). The gene discussed is SUPT6H; the disease is neuroblastoma.